Whalesbook
Bhaiyo, yeh hai full story! Goldline Pharmaceutical ka IPO toh pehle hi din zabardast raila dikha gaya. Overall booking 20.79 times ho gayi!
Iska sabse badi wajah the hamare retail investors, jinhone apni quota 34.07 times bhar di. Non-institutional investors bhi peeche nahi rahe, unki booking 18.07 times rahi. Bas Qualified Institutional Buyers (QIBs) ne thoda kam interest dikhaya, sirf 1.31 times ki booking hui.
Company is IPO se lagbhag ₹11.61 crore jod rahi hai, jiska share price ₹41 se ₹43 ke beech hai. Aur suno, is pure amount mein se ₹8.35 crore seedha loan chukane mein jayega. Matlab, company pehle apna debt kam karne par focus kar rahi hai, phir expansion ka dekha jayega. Yeh India mein common strategy hai, taaki interest ka kharcha kam ho aur profit badhe.
Ab baat karte hain RFBL Flexi Pack ki. Inka public issue thoda slow raha, pehle din sirf 1.18 times subscribe hua. Yahan bhi Non-institutional investors sabse aage the (1.59 times), uske baad QIBs (1.11x) aur phir retail investors (1.07x).
Yeh company ₹35.33 crore jod rahi hai, share price ₹47 to ₹50 ke range mein hai. RFBL ka plan growth-oriented hai. Is fund se Gujarat mein ek nayi manufacturing facility lagane ke liye land kharidenge aur banayenge (₹12.4 crore), aur baaki ₹17.76 crore working capital badhane mein lagayenge. Packaging sector future mein grow karne wala hai, kyunki FMCG aur pharma companies ki demand badh rahi hai.
Market mein aajkal investors thode selective ho gaye hain. Quality aur price dono dekhte hain. Goldline ka asset-light model hai, matlab woh third-party manufacturers par depend karte hain. IPO se pehle P/E ratio 9.75x tha, jo IPO ke baad 15.19x ho gaya hai. RFBL ka post-IPO P/E bhi upper band par lagbhag 15.19x hai, jo competitors jaise Uma Converter aur Sabar Flex ke aas paas hai. Lekin RFBL par thoda zyada debt hai (Debt/Equity 0.80), aur unka revenue ka 62% trading se aata hai.
Goldline ke liye risk yeh hai ki woh zyada paisa debt chukane mein laga rahe hain, growth pe kam. Aur unpar tax ke ₹3.34 crore ke proceedings bhi chal rahe hain. RFBL ke liye, unka 93.85% revenue sirf top 5 customers se aata hai, matlab customer concentration ka risk hai. Unke paas formal long-term contracts bhi nahi hain. Manufacturing ke alawa trading se bhi revenue aa raha hai, jismein profit margin kam hota hai. Factory utilization bhi abhi 52% hai.
Dono IPOs 14th May 2026 ko band ho rahe hain. Dekhte hain listing mein kaise perform karte hain aur investors ko kya dikhate hain.